home All News open_in_new Full Article

Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada

Postpartum depression (PPD) affects up to one in five Canadian women1; it is the most common complication2 related to childbearing and a leading cause of maternal death in Canada3 Left untreated, PPD can have short- and long-term consequences on maternal health, child development and family well-being4,5,6 ZURZUVAE is a 14-day, oral single course of treatment […]


today 1 week ago attach_file Economics



ID: 1843246637
Add Watch Country

arrow_drop_down